$DRMA

Dermata Therapeutics, Inc.

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

CEO
Mr. Gerald T. Proehl
Employees
9
Headquarters
San Diego, CA
Sector
Healthcare
Industry
Biotechnology
Website
dermatarx.com

Key stats

Market Cap
$6.39M
P/E Ratio
Avg Volume (3M)
742.79K
EPS
-$4.06
Day's Range
$1.27 – $1.33

Fundamentals as of Sep 01, 2026